Literature DB >> 3384947

Preservation of the glomerular capillary ultrafiltration coefficient during rat nephrotoxic serum nephritis by a specific leukotriene D4 receptor antagonist.

K F Badr1, G F Schreiner, M Wasserman, I Ichikawa.   

Abstract

Leukotriene D4, a potent biologically active lipoxygenase derivative of arachidonic acid in activated leukocytes, depresses the glomerular capillary ultrafiltration coefficient (Kf) and contracts mesangial cells in culture. We therefore investigated its potential role in mediating the reduction in nephron filtration rate seen after induction of experimental nephrotoxic serum (NTS)-induced glomerulonephritis in the rat. Micropuncture measurements were performed in euvolemic Munich-Wistar rats 2 h after i.v. administration of 0.8 ml of rabbit serum (group 1, n = 6), 0.8 ml of rabbit anti-rat glomerular basement membrane antibody in the absence (group 2, n = 8), or presence (group 3, n = 7) of the new highly specific LTD4 receptor antagonist SK&F 104353. Quantitation of antibody binding and neutrophil infiltration revealed no differences between groups 2 and 3. Antagonism of endogenous LTD4 actions, however, was associated with prevention of the NTS-induced fall in SNGFR because of the abrogation of the fall in Kf which characterizes this form of experimental glomerulonephritis. Antagonism of endogenous LTD4 had no effect on the NTS-induced increases in pre- and postglomerular arteriolar resistances, and did not affect nephron plasma flow rate or net transcapillary hydraulic pressure difference. The observed highly localized protective action of the LTD4 antagonist on the glomerular capillary points to a possibly major functional role for intraglomerularly released LTD4, likely originating from infiltrating leukocytes, in the pathophysiology of this form of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384947      PMCID: PMC442614          DOI: 10.1172/JCI113509

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde.

Authors:  J W Viets; W M Deen; J L Troy; B M Brenner
Journal:  Anal Biochem       Date:  1978-08-01       Impact factor: 3.365

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Nephrotoxic serum nephritis. 3. Correlation of proteinuria, excretion of the glomerular basement membrane-like protein, and changes in the ultrastructure of the glomerular basement membrane as visualized with lanthanum.

Authors:  N F Gang; E Trachtenberg; J Allerhand; N Kalant; W Mautner
Journal:  Lab Invest       Date:  1970-10       Impact factor: 5.662

4.  Glomerular basement membrane damage in immunological glomerulonephritis.

Authors:  D Hawkins; C G Cochrane
Journal:  Immunology       Date:  1968-05       Impact factor: 7.397

5.  Plasma protein handling in the rat kidney: micropuncture experiments in the acute heterologous phase of anti-GBM-nephritis.

Authors:  R G Galaske; C A Baldamus; H Stolte
Journal:  Pflugers Arch       Date:  1978-08       Impact factor: 3.657

6.  Determinants of glomerular filtration in experimental glomerulonephritis in the rat.

Authors:  D A Maddox; C M Bennett; W M Deen; R J Glassock; D Knutson; T M Daugharty; B M Brenner
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

7.  Pathophysiology of experimental glomerulonephritis in rats.

Authors:  M E Allison; C B Wilson; C W Gottschalk
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

8.  Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient.

Authors:  W M Deen; J L Troy; C R Robertson; B M Brenner
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  Acute effects of antiglomerular basement membrane antibody on the process of glomerular filtration in the rat.

Authors:  R C Blantz; C B Wilson
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  6 in total

1.  Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis.

Authors:  K A Munger; A Montero; M Fukunaga; S Uda; T Yura; E Imai; Y Kaneda; J M Valdivielso; K F Badr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.

Authors:  K F Badr; D K DeBoer; M Schwartzberg; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Predominant functional roles for thromboxane A2 and prostaglandin E2 during late nephrotoxic serum glomerulonephritis in the rat.

Authors:  K Takahashi; G F Schreiner; K Yamashita; B W Christman; I Blair; K F Badr
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Leukotriene D4 is a mediator of proteinuria and glomerular hemodynamic abnormalities in passive Heymann nephritis.

Authors:  T Katoh; E A Lianos; M Fukunaga; K Takahashi; K F Badr
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Mesangial cell immune injury. Hemodynamic role of leukocyte- and platelet-derived eicosanoids.

Authors:  B A Bresnahan; S Wu; F J Fenoy; R J Roman; E A Lianos
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  The effects of R-75,317 on antiglomerular basement membrane glomerulonephritis in rats.

Authors:  M Miyamoto; H Koike; T Sada; Y Ijima; J Fukushige; N Nakamura
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.